Evaxion AS (EVAX)
3.07
+0.02
(+0.66%)
USD |
NASDAQ |
Oct 09, 16:00
3.10
+0.03
(+0.98%)
After-Hours: 20:00
Evaxion Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.045M |
| September 30, 2023 | -4.361M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -8.166M |
| Date | Value |
|---|---|
| December 31, 2021 | -4.147M |
| September 30, 2021 | -6.251M |
| June 30, 2021 | -7.476M |
| March 31, 2021 | -4.025M |
| December 31, 2020 | -4.407M |
| September 30, 2020 | -2.841M |
| June 30, 2020 | -2.325M |
| March 31, 2020 | -2.950M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -25.16M |
| DBV Technologies SA | -52.52M |
| Cellectis SA | -14.34M |
| Akari Therapeutics Plc | -3.112M |
| Ascendis Pharma A/S | 327.52M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -119.6% |